PolyMedix
Eric McAllister, M.D., D.Phil. (Ph.D.)
Vice President, Clinical Development: Eric McAllister, M.D., D.Phil. (Ph.D.)
Eric brings over 30 years of industry and clinical trials experience, most recently as Sr. Vice President of Clinical Development at CombinatoRx Inc. Previously with Sicor Pharmaceuticals, TAP Pharmaceuticals, Cholestech Inc., Bristol-Myers Squibb, G.D. Searle, and Syntex Pharmaceuticals, Dr. McAllister also spent seven years as a clinical investigator with MEDStudies. He has an M.D. from Dalhousie University, and a D.Phil. (Ph.D.) degree from Oxford University, and was also a Rhodes Scholar. Dr. McAllister has worked on the development of such major pharmaceutical products as Lupron, Pravachol, Capoten, Kerlone, Cardene, Calan, Avandia, Actos, Teveten, and Atacand.
Eric McAllister, M.D., D.Phil. (Ph.D.)
Vice President, Clinical Development: Eric McAllister, M.D., D.Phil. (Ph.D.)
Eric brings over 30 years of industry and clinical trials experience, most recently as Sr. Vice President of Clinical Development at CombinatoRx Inc. Previously with Sicor Pharmaceuticals, TAP Pharmaceuticals, Cholestech Inc., Bristol-Myers Squibb, G.D. Searle, and Syntex Pharmaceuticals, Dr. McAllister also spent seven years as a clinical investigator with MEDStudies. He has an M.D. from Dalhousie University, and a D.Phil. (Ph.D.) degree from Oxford University, and was also a Rhodes Scholar. Dr. McAllister has worked on the development of such major pharmaceutical products as Lupron, Pravachol, Capoten, Kerlone, Cardene, Calan, Avandia, Actos, Teveten, and Atacand.